BRIEF-Meridian Bioscience Reports Record Second Quarter Fiscal 2022 Operating Results
* MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS
* SEES FY ADJUSTED EARNINGS PER SHARE
* Q2 REVENUE ROSE 30 PERCENT TO
* SEES CONSOLIDATED FY NET REVENUE
* QTRLY EARNINGS PER SHARE
* QTRLY ADJUSTED EARNINGS PER SHARE